The central challenge to developing safer and more effective treatments for people with systemic lupus erythematosus (SLE) stems from the tremendous clinical and mechanistic heterogeneity of SLE.

To overcome this challenge, the Lupus Research Alliance (LRA) has established the Global Team Science Award (GTSA) which provides up to US$3 million over three years to support interdisciplinary, collaborative, and highly synergistic projects that focus on unraveling human lupus heterogeneity. Successful teams will push the boundaries of innovation and bridge research and clinical efforts in lupus by applying cutting-edge technologies to address critical questions that could bring about breakthroughs in lupus care, research, or drug development.

The LRA invites established investigators worldwide and across scientific disciplines to submit Letters of Intent (LOIs) for four-month planning grants (up to US$10,000 each) to assemble competitive multi-institutional teams to develop and submit full applications. The LRA anticipates that up to five planning grants and then one GTSA will be awarded.

See complete details about this award (pdf)